Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma

Abstract

This case highlights the diversity of potential endocrine toxicity of checkpoint inhibitors. Because acute adrenal crisis may be associated with substantial morbidity and mortality, physicians must be aware of these rare adverse events to allow an early diagnosis.